Tata India Pharma & Healthcare Fund (IDCW) RI
Last Updated NAV Date: 30 Jul 2026
3 Year Returns
17.91%
NAV (₹)
32.3883
1 Day NAV Change
-0.16%
No chart data available for this period.
Fund Details
| Min. SIP Amount | ₹ 100 |
| Min. Lumpsum Amount | ₹ 5000 |
| AUM | ₹ 1455.16 Cr |
| Expense Ratio | 2.25% |
| Lock-in Period | No Lock-in Period |
| Inception Date | 28 Dec 2015 |
| Fund Age | 10 Yrs |
Exit Load
0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment.
Fund’s Investment Objective
To seek long term capital appreciation by investing at least 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sector in India.
Calculate Your Mutual Fund Returns
Returns Estimator
Estimation is based on the past performance
Expected Rate of Return
The value of your investment after 5 Years will be
₹4,12,432
Invested Amount
₹3,00,000
Est. Returns
₹1,12,432
Scheme’s Historical Return
1 Month Return5.29%
3 Month Return8.17%
6 Month Return14.84%
1 Year Return3.88%
3 Year Return17.91%
5 Year Return13.21%
Asset Allocation
AUM
₹1,33,309.00 Cr
Cash Holdings
21.45%
Equity
70.84%
Cash
21.45%
Debt
1.71%
Other
6%
Sector Holdings
Last Updated: 30 Jun 2026| Sectors | Allocation | Weightage | Value (in Cr.) |
|---|---|---|---|
| Pharmaceuticals | 61.29% | ₹ 891.825 | |
| Healthcare | 33.17% | ₹ 482.705 | |
| Agro Chemicals | 4.28% | ₹ 62.28 | |
| FMCG | 1.26% | ₹ 18.353 |
Stock Holdings
Last Updated: 30 Jun 2026| Name | Allocation | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|---|
| Sun Pharma.Inds. | 8.51% | ₹ 123.889 | Pharmaceuticals | |
| Max Healthcare | 5.68% | ₹ 82.712 | Healthcare | |
| Health.Global | 5.52% | ₹ 80.314 | Healthcare | |
| Divi's Lab. | 5.12% | ₹ 74.549 | Pharmaceuticals | |
| Abbott India | 4.97% | ₹ 72.384 | Pharmaceuticals | |
| Cipla | 4.77% | ₹ 69.44 | Pharmaceuticals | |
| Apollo Hospitals | 4.61% | ₹ 67.151 | Healthcare | |
| Rainbow Child. | 4.42% | ₹ 64.253 | Healthcare | |
| Dr Reddy's Labs | 4.26% | ₹ 62.045 | Pharmaceuticals | |
| Glaxosmi. Pharma | 4.12% | ₹ 60.002 | Pharmaceuticals |
Fund Manager Details
From 6thSeptember 2024 onwards With Tata Asset Management Private Limited as Assistant Fund Manager & Research Analyst having responsibilities for Healthcare & Chemicals sector coverage, reporting to Chief Investment Officer - Equities. From October2022 to September 2024 With Incred Asset Management as AVP Investments having responsibilities for Automobile, Healthcare & Diversified sectors reporting to Fund Manager and CEO/CIO. From April 2022 to October 2022 With Kotak Investment Banking as Assistant Vice President-Corporate Advisory having responsibilities for Deal sourcing and reporting to Managing Director-Corporate Advisory Group. From November202 0 to April202 2 With Incred Asset Management as AVP Investments having responsibilities as Healthcare Analyst reporting to Fund Manager. From September20 19 to November 2020 With Emkay Global as Research Associate having responsibilities for coverage of healthcare sector stocks reporting to Lead Analyst. From June 2019 to September 2019 With Evalueserve (Client - Deutsche Securities) as Research Lead having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. From May 2016 to June20 19 With Motilal Oswal Financial Services as Assistant manager - Research having responsibilities for coverage of healthcare/pharma stocks reporting to Lead Analyst. o BBA (Banking & Insurance), PGDM- IMT Ghaziabad
Risk-O-Meter
Very High Risk
Investors understand that their principal will be at Very High Risk
Risk Scale
Low
Moderately Low
Moderate
Moderately High
High
Very High
AMC Information
Tata Mutual Fund
Funds Managed
68
Assets Managed
₹ 2,31,388.31 Cr
Contact Details
Registered Address
1903, B-Wing, Parinee Crescenzo,G-Block, Bandra Kurla Complex,Bandra East Mumbai - 400051
Managing Director
Anand Vardarajan
Chief Executive Officer
Anand Vardarajan
Compliance Officer
Mr. Padmanabhan Ramanatha
Mutual Funds Calculators
Explore Mutual Funds by Types
Open NFOs
Explore Popular AMCs
SBI Mutual FundICICI Prudential Mutual FundHDFC Mutual FundNippon India Mutual FundKotak Mahindra Mutual FundAditya Birla Sun Life Mutual FundUTI Mutual FundAxis Mutual FundDSP Mutual FundMirae Asset Mutual FundTata Mutual FundBandhan Mutual FundEdelweiss Mutual FundPPFAS Mutual FundMotilal Oswal Mutual FundInvesco Mutual FundHSBC Mutual FundFranklin Templeton Mutual FundCanara Robeco Mutual FundQuant Mutual FundSundaram Mutual FundBaroda BNP Paribas Mutual FundLIC Mutual FundWhiteOak Capital Mutual Fund
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
You can withdraw your investment from Tata India Pharma & Healthcare Fund (IDCW) RI through your mutual fund app, AMC website, or demat or stock broker online account at the applicable NAV.
The minimum investment for Tata India Pharma & Healthcare Fund (IDCW) RI is ₹ 5000 for Lumpsum and ₹ 100 for SIP. You can open a demat account or login to the existing stock broker online account to get started.
Tata India Pharma & Healthcare Fund (IDCW) RI has a lock-in period of No Lock-in Period. Schemes with a lock-in restrict withdrawals or redemptions for that duration, while schemes with no lock-in allow you to redeem anytime.
The average annualized return of Tata India Pharma & Healthcare Fund (IDCW) RI over the past three years is 17.91%.
The current NAV of Tata India Pharma & Healthcare Fund (IDCW) RI is 32.3883.
The Expense ratio of Tata India Pharma & Healthcare Fund (IDCW) RI is 2.25%. It is an annual charge for running the mutual fund. You can find the same on the factsheet and the Asset Management Companies website.
The latest AUM of the Tata India Pharma & Healthcare Fund (IDCW) RI fund is ₹ 1455.16 Cr. It represents the total assets held and managed by the fund.
The exit load for Tata India Pharma & Healthcare Fund (IDCW) RI is 0.25% of NAV if redeemed/switched out before 30 Days from the date of allotment..
The fund managers of the Tata India Pharma & Healthcare Fund (IDCW) RI are Rajat Srivastava. However, with management's discretion, the fund manager could also change during the tenure.
Tata India Pharma & Healthcare Fund (IDCW) RI was launched on 28 Dec 2015. Since then, the fund has formed an NAV (Net Asset Value) of 32.3883.
Download the AR Invest App
- 5000+ Schemes
- Personalized Solutions
- Expert Insights
